One million strong: colorectal cancer survivors

Article

suzanne lindley blog image

In February, I helped to host a survivor fashion show to create awareness about living with liver tumors. Among those who modeled were a number of stage 4 colon cancer survivors. Shocking to many were the young ages of our survivors. Out of the nine colon cancer survivors that participated, EIGHT were diagnosed before age 50! Even more notable is the fact that four of us have lived with metastatic disease for more than eight years! The ages are sobering; the longevity exciting!It has been 14 years since my diagnosis with colon cancer, and I'm thankful to see the progress. Way back when we talked about survival of stage 4 colon cancer in months, not years! How things have changed! In the early days of my diagnosis it took a great deal of courage to say "colon" in anything other than a hushed voice.In the years since, we've made great progress thanks to ACOR (ACOR.org), Chris 4 Life (chris4life.org), Colon Cancer Alliance (ccalliance.org), COLONTOWN (facebook.com/colontown), and Fight Colorectal Cancer (fightcolorectalcancer.org) ... among others. Advocates have shared their stories and offered support, taken their voices to Capitol Hill (Call on Congress with Fight Colorectal Cancer is just around the corner!), and created awareness programs that are truly making colon cancer preventable, treatable and beatable!Research has paved the way for numerous novel treatments and procedures. What was dealt to me as a death sentence can often be managed as a chronic disease. For some that have seen their disease spread it is even possible to downstage to NED, or no evidence of disease. We are able to live longer and better in spite of advanced cancer. I have benefited from the research and advocacy these past 14 years. The much needed momentum has provided time, options and hope for cancer patients everywhere. For others, awareness has prevented colon cancer. Be a part of the momentum for colorectal cancer. You can make a difference in the fight by joining Fight Colorectal Cancer's "One Million Strong." Visit the ONE MILLION STRONG TOOLBOX as a guide for how you can be involved in the fight against colorectal cancer.We are stronger together! One million strong!

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content